Alseres Pharmaceuticals, Inc. (OTCMKTS:ALSE) shares after opening at $0.05 moved to $0.06 on last trade day and at the end of the day closed at $0.0580. Company price to cash ratio in past twelve months was calculated as 19.11. Alseres Pharmaceuticals, Inc. (OTCMKTS:ALSE) showed a positive weekly performance of 45.00%.
Can-Fite BioPharma Ltd (NYSEMKT:CANF), a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced that it has filed its 2013 Annual Report on Form 20-F with the U.S. Securities and Exchange Commission. Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) shares advanced 11.08% in last trading session and ended the day on $5.78. Can Fite Biopharma Ltd (ADR) (NYSEMKT:CANF) yearly performance is 12.23%.
Acceleron Pharma (NASDAQ:XLRN) shares gained 20.43% to $40.79 after Form 8-K for Acceleron Pharma showed that Celgene (NASDAQ:CELG) will buy 1.1 million shares for $47.15 million. Acceleron Pharma Inc (NASDAQ:XLRN) shares moved up 13.17% in last trading session and was closed at $38.33 while trading in range of $37.40 – $42.24 – Acceleron Pharma Inc (NASDAQ:XLRN) year to date (YTD) performance is -3.21%.
MannKind (NASDAQ:MNKD) surged 95.77% to $7.87 after the company confirmed that the FDA Advisory Committee recommended the approval of the company’s diabetes drug AFREZZA. MannKind Corporation (NASDAQ:MNKD) weekly performance is 20.52%. On last trading day company shares ended up $6.99. MannKind Corporation (NASDAQ:MNKD) distance from 50-day simple moving average (SMA50) is 23.75%. Analysts mean target price for the company is $7.07.